Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDTarsus Pharmaceuticals Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 5 | -$0.47 | -$0.18 | -$0.37 |
| Q2 2026 | 4 | -$0.25 | -$0.01 | -$0.15 |
| Q3 2026 | 1 | -$0.17 | -$0.16 | -$0.16 |
| Q4 2026 | 2 | $0.08 | $0.08 | $0.08 |
| Q1 2027 | 2 | $0.14 | $0.15 | $0.15 |
| Q2 2027 | 1 | $0.59 | $0.64 | $0.61 |
| Q3 2027 | 1 | $0.70 | $0.77 | $0.73 |
| Q4 2027 | 2 | $0.99 | $1.08 | $1.02 |
Tarsus Pharmaceuticals Inc Earnings Date And Information
Tarsus Pharmaceuticals Inc last posted its earnings results on Monday, February 23rd, 2026. The company reported $-0.2 earnings per share for the quarter, missing analysts' consensus estimates of $-0.103 by $0.097. The company had revenue of 151.67 M for the quarter and had revenue of 451.36 M for the year. Tarsus Pharmaceuticals Inc has generated $-2 earnings per share over the last year ($-1.59 diluted earnings per share) and currently has a price-to-earnings ratio of -41.76. Tarsus Pharmaceuticals Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Tarsus Pharmaceuticals Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/23/2026 | Q4 2025 | -$0.10 | -$0.20 | -0.1 | $144.57 M | $151.67 M |
| 11/04/2025 | Q3 2025 | -$0.35 | -$0.30 | 0.05 | $115.23 M | $118.70 M |
| 08/06/2025 | Q2 2025 | -$0.33 | -$0.48 | -0.15 | $95.68 M | $102.66 M |
| 05/01/2025 | Q1 2025 | -$0.69 | -$0.64 | 0.05 | $72.43 M | $78.34 M |
| 02/25/2025 | Q4 2024 | -$0.68 | -$0.60 | 0.08 | $58.80 M | $66.41 M |
| 11/13/2024 | Q3 2024 | -$0.94 | -$0.61 | 0.33 | $43.18 M | $48.12 M |
| 08/08/2024 | Q2 2024 | -$0.98 | -$0.88 | 0.1 | $32.33 M | $40.81 M |
| 05/08/2024 | Q1 2024 | -$1.15 | -$1.01 | 0.14 | $17.89 M | $27.61 M |
| 02/27/2024 | Q4 2023 | -$1.37 | -$1.31 | 0.06 | N/A | $13.08 M |
| 11/09/2023 | Q3 2023 | -$1.40 | -$1.28 | 0.12 | N/A | $1.87 M |
| 08/10/2023 | Q2 2023 | -$1.08 | -$1.17 | -0.09 | N/A | $0 |
| 05/09/2023 | Q1 2023 | -$0.95 | -$0.88 | 0.07 | N/A | $2.50 M |
| 03/16/2023 | Q4 2022 | N/A | -$0.53 | N/A | N/A | $10.00 M |
| 11/09/2022 | Q3 2022 | -$0.98 | -$0.84 | 0.14 | N/A | $0 |
| 08/11/2022 | Q2 2022 | -$0.65 | -$0.24 | 0.41 | N/A | $15.28 M |
| 05/11/2022 | Q1 2022 | N/A | -$0.98 | N/A | N/A | $539.00 K |
| 03/14/2022 | Q4 2021 | -$0.77 | -$0.72 | 0.05 | N/A | $338.00 K |
| 11/10/2021 | Q3 2021 | N/A | -$0.76 | N/A | N/A | $1.24 M |
| 08/04/2021 | Q2 2021 | N/A | $0.31 | N/A | N/A | $22.02 M |
| 05/11/2021 | Q1 2021 | -$0.64 | $0.51 | 1.15 | N/A | $33.43 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Tarsus Pharmaceuticals Inc Earnings: FAQ's
The conference call for Tarsus Pharmaceuticals Inc's latest earnings report can be listened to online.
The conference call transcript for Tarsus Pharmaceuticals Inc's latest earnings report can be read online.
Tarsus Pharmaceuticals Inc (:TARS) has a recorded annual revenue of $451.36 M.
Tarsus Pharmaceuticals Inc (:TARS) has a recorded net income of $-66,418,000.Tarsus Pharmaceuticals Inc has generated $-1.59 earnings per share over the last four quarters.
Tarsus Pharmaceuticals Inc (:TARS) has a price-to-earnings ratio of -41.76 and price/earnings-to-growth ratio is -0.56.